Dashboard
1
High Management Efficiency with a high ROCE of 12.41%
2
Healthy long term growth as Net Sales has grown by an annual rate of 15.70%
3
Positive results in Jun 25
4
With ROE of 10.50%, it has a fair valuation with a 3.34 Price to Book Value
5
Majority shareholders : Mutual Funds
6
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
CAD 1,461 Million (Small Cap)
30.00
NA
0.00%
0.82
10.50%
3.12
Revenue and Profits:
Net Sales:
199 Million
(Quarterly Results - Jun 2025)
Net Profit:
14 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.9%
0%
-8.9%
6 Months
-4.91%
0%
-4.91%
1 Year
-9.6%
0%
-9.6%
2 Years
13.0%
0%
13.0%
3 Years
1.88%
0%
1.88%
4 Years
-15.35%
0%
-15.35%
5 Years
-6.25%
0%
-6.25%
Jamieson Wellness, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.70%
EBIT Growth (5y)
10.41%
EBIT to Interest (avg)
7.64
Debt to EBITDA (avg)
2.95
Net Debt to Equity (avg)
0.79
Sales to Capital Employed (avg)
0.78
Tax Ratio
31.59%
Dividend Payout Ratio
64.08%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
12.41%
ROE (avg)
11.77%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
3.15
EV to EBIT
18.61
EV to EBITDA
15.69
EV to Capital Employed
2.18
EV to Sales
2.43
PEG Ratio
0.52
Dividend Yield
NA
ROCE (Latest)
11.71%
ROE (Latest)
10.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 1 Schemes (0.06%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
199.10
184.80
7.74%
Operating Profit (PBDIT) excl Other Income
28.40
24.20
17.36%
Interest
5.90
6.80
-13.24%
Exceptional Items
0.00
0.00
Consolidate Net Profit
13.80
8.30
66.27%
Operating Profit Margin (Excl OI)
117.50%
105.10%
1.24%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 7.74% vs 10.26% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 66.27% vs 15.28% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
733.80
676.20
8.52%
Operating Profit (PBDIT) excl Other Income
112.40
107.70
4.36%
Interest
29.00
27.60
5.07%
Exceptional Items
12.40
7.90
56.96%
Consolidate Net Profit
51.10
46.00
11.09%
Operating Profit Margin (Excl OI)
127.90%
129.20%
-0.13%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 8.52% vs 23.53% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 11.09% vs -12.88% in Dec 2023
About Jamieson Wellness, Inc. 
Jamieson Wellness, Inc.
Pharmaceuticals & Biotechnology
Jamieson Wellness Inc is a Canada-based company, which operates as the health and wellness company. The Company develops, manufactures and markets brand of vitamins and natural health products. The Company offers vitamins, minerals and supplements (VMS) products and certain over-the-counter remedies through Jamieson and LVHS brands, as well as sports nutrition products through Progressive, Precision and Iron Vegan brands. The Company offers manufacturing and product development services on a contract manufacturing basis to select blue-chip consumer health companies and retailers worldwide. Additionally, the Company also offers services to Strategic Partners Business customers, including regulatory advice, new product development and distribution services and industry insights.
Company Coordinates 
Company Details
1 Adelaide Street East, Suite 2200 , TORONTO CA : M5C 2V9
Registrar Details






